Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
about
Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factorsApoptomiRs of Breast Cancer: Basics to ClinicsMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?A multi-targeted approach to suppress tumor-promoting inflammationThe induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrestBreast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesReconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.Regulation of human growth hormone receptor expression by microRNAsMicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatinOverexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophyFormononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cellsThe oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.Identification of Reliable Reference Genes for Quantification of MicroRNAs in Serum Samples of Sulfur Mustard-Exposed Veterans.Circulating cell-free miRNAs as biomarker for triple-negative breast cancerMicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer.MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.Deregulation of the miR-16-KRAS axis promotes colorectal cancer.Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.Roles of mitochondrial transcription factor A and microRNA‑590‑3p in the development of colon cancer.Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.The validity of circulating microRNAs in oncology: five years of challenges and contradictions.Emerging hormonal treatments for menopausal symptoms.MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.Oncogenic long noncoding RNA landscape in breast cancer.Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion.Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1.Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.MiR-16-1 plays a role in reducing migration and invasion of glioma cells.Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins.MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary glandDetermination of absolute expression profiles using multiplexed miRNA analysis.MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.
P2860
Q26771541-33307A60-633B-4081-B7A2-6970015F0F86Q28072414-83592F23-303B-4D8A-A91E-8BD57290FCDEQ28081081-70E72424-C133-40C0-A838-0E1445FCC3ADQ28389159-2D2E1CB8-4893-48D4-A259-660988F2E7B8Q28393278-119FD9B2-F83E-4805-9D10-294FCCE84A0DQ28484878-3DB157FE-0701-4E93-8971-E0102BE17927Q30409045-D3CF33FA-151F-4105-9B1D-3357AD478E12Q31036763-DFD0FC49-816F-42D8-A099-EE01A1871642Q33631926-F62C257F-C18D-4F2D-80F7-68CDE19F3D67Q34093885-6518BCE6-4EF1-431E-B466-410E0A2E8AD4Q34351474-F3C96E43-3C22-48A1-AFEC-7C43E56B9219Q35206519-5834D003-49BD-4798-B133-AAFB1DC3F280Q35557991-B38A4395-DF4F-4473-A24B-DE7D22C7E9D0Q35585464-4D01CEAC-35DF-4CCC-BCCB-3709708D51A2Q35677914-E5FD51CB-F30A-40F2-9629-F967D9958214Q36148790-162468C8-0D0C-4CDD-AD74-81531B54AEF5Q36285931-BC69DA8F-FA79-45E1-9157-2FE77E4042DEQ36640282-76BDFD9D-2E14-47E5-A544-BB804DB9CCEDQ37269100-E4221455-17ED-4AFA-B07B-30191119AA20Q37421726-72C1D6C1-E22D-4130-B634-F5730CF0386BQ37690705-260F0014-EB0C-4ECF-BF88-7FBC93581C51Q37707666-F7827CE3-0583-40FF-86C0-2B9DD3754F50Q37746255-55BF1B94-8BAD-459D-A2B4-0B7524F7D643Q38198366-8AADC2A0-B8A2-461B-84B7-AF988FB7C326Q38307019-87674BFC-A127-4E53-9C0A-F5593089C1F5Q38652482-A6E7436C-C046-4C28-B6C5-2CE43B1ACCD6Q38661848-BBD9FC07-83CF-475B-9F4B-2D1316A3B7DCQ38664338-37217CFE-0A4B-4635-81D4-7AC3B0FE61A2Q38773516-335DBF2F-583C-409F-B692-3AE4E9B8FD27Q38810546-4B31BED6-B550-4907-854E-CF10D4CB2645Q38849205-51202C9C-460E-4299-85FF-57E00DBFB3DAQ38910759-1A4BE2B9-A027-4C33-A00A-3F8BB104354FQ39137856-3E9951A0-4F4F-494A-A398-91E85744834AQ39149974-FA760D65-7C85-4194-AFF5-3A5DE27E83EFQ39178990-EAE10CE6-63E1-460E-AEC9-416BA2434B81Q39240322-3B9F6C65-19EA-4FCE-B45E-4065B0847CA3Q39928785-DFE0523A-7DBE-4975-856F-F027146B4D21Q40747141-39F90CE0-0FD4-4817-9D6E-3541ECD0BCCFQ41007207-5E5B0644-CBE3-4DE2-BCDF-4EE6984A1BFFQ41025694-6FF65858-88EB-4264-95C6-C2E08F4FD5F8
P2860
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Downregulation of the tumor-su ...... s to breast cancer development
@ast
Downregulation of the tumor-su ...... s to breast cancer development
@en
Downregulation of the tumor-su ...... s to breast cancer development
@en-gb
Downregulation of the tumor-su ...... s to breast cancer development
@nl
type
label
Downregulation of the tumor-su ...... s to breast cancer development
@ast
Downregulation of the tumor-su ...... s to breast cancer development
@en
Downregulation of the tumor-su ...... s to breast cancer development
@en-gb
Downregulation of the tumor-su ...... s to breast cancer development
@nl
prefLabel
Downregulation of the tumor-su ...... s to breast cancer development
@ast
Downregulation of the tumor-su ...... s to breast cancer development
@en
Downregulation of the tumor-su ...... s to breast cancer development
@en-gb
Downregulation of the tumor-su ...... s to breast cancer development
@nl
P2093
P2860
P3181
P356
P1476
Downregulation of the tumor-su ...... s to breast cancer development
@en
P2093
Leandro Venturutti
Martin A Rivas
Patricia V Elizalde
Roxana Schillaci
Tim Hui-Ming Huang
Yi-Wen Huang
P2860
P2888
P3181
P356
10.1186/BCR3187
P407
P577
2012-01-01T00:00:00Z
P5875
P6179
1029351637